Hepsen Mine SERİN, Erdem ŞİMŞEK, Seda KANMAZ, Sanem YILMAZ, Gül AKTAN, Hasan TEKGÜL, Sarenur GÖKBEN, Cenk ERASLAN, Hatice Serpil ERERMİŞ, Sezen KÖSE

Neuropsychological outcome in cases with acute disseminated encephalomyelitis

Background and objectives. Acute disseminated encephalomyelitis (ADEM) is an immune-mediated, inflammatory and demyelinating disorder of the central nervous system. There have been a few studies in recent years on the fact that these cases have neurocognitive impairment. The purpose of this study is to evaluate the neurocognitive outcome and quality of life in cases with ADEM. Methods. Eleven cases who were on follow-up between 2008 and 2017 were included in the study, systemic, neurological and psychiatric examinations were done. All magnetic resonance images were re-evaluated. The neuropsychiatric evaluation was performed by clinical examination and psychometric scales; (1) The Pediatric Quality of Life Inventory 4.0, (2) Child Behavior Checklist, (3) Children’s Depression Inventory, (4) The Wechsler Intelligence Scale for Children-Revised and (5) Continuous Performance Test. The cases in our study underwent neuropsychiatric evaluation 3-42 months after the diagnosis of ADEM had been established. Results. Nine cases (81.8%) fully recovered without neurologic deficit. One case (9.1%) had a psychiatric disorder. During follow-up, cognitive and psychiatric problems were encountered in half of the cases (54.5%). Most of the cases with basal ganglia involvement (80%) displayed attention deficit and cognitive problems. Conclusion. In particular, cases with basal ganglia involvement should be followed carefully in terms of attention and cognitive problems.

PDF

___

1. Jayakrishnan MP, Krishnakumar P. Clinical profile of acute disseminated encephalomyelitis in children. J Pediatr Neurosci 2010; 5: 111-114.
2. Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomyelitis: an update. Arch Neurol 2005; 62: 1673-1680.
3. Pohl D, Alper G, Van Haren K, et al. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology 2016; 87(9 Suppl 2): S38-S45.
4. Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68(16 Suppl 2): S7-S12.
5. Khong PL, Ho HK, Cheng PW, Wong VCN, Goh W, Chan FL. Childhood acute disseminated encephalomyelitis: the role of brain and spinal cord MRI. Pediatr Radiol 2002; 32: 59-66.
6. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term followup study of 84 pediatric patients. Neurology 2002; 59: 1224-1231.
7. Visudtibhan A, Tuntiyathorn L, Vaewpanich J, et al. Acute disseminated encephalomyelitis: a 10-year cohort study in Thai children. Eur J Paediatr Neurol 2010; 14: 513-518.
8. Anlar B, Basaran C, Kose G, et al. Acute disseminated encephalomyelitis in children: outcome and prognosis. Neuropediatrics 2003; 34: 194-199.
9. Tenembaum S, Chitnis T, Ness J, Hahn JS; International Pediatric MS Study Group. Acute disseminated encephalomyelitis. Neurology 2007; 68(16 Suppl 2): S23-S36.
10. Hahn CD, Miles BS, MacGregor DL, Blaser SI, Banwell BL, Hetherington CR. Neurocognitive outcome after acute disseminated encephalomyelitis. Pediatr Neurol 2003; 29: 117-123.
11. Jacobs RK, Anderson VA, Neale JL, Shield LK, Kornberg AJ. Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset. Pediatr Neurol 2004; 3: 191-197.
12. Kuni BJ, Banwell BL, Till C. Cognitive and behavioral outcomes in individuals with a history of acute disseminated encephalomyelitis (ADEM). Dev Neuropsychol 2012; 37: 682-696.
13. Parrish JB, Weinstock-Guttman B, Smerbeck A, Benedict RHB, Yeh EA. Fatigue and depression in children with demyelinating disorders. J Child Neurol 2013; 28: 713-718.
14. Tan A, Hague C, Greenberg BM, Harder L. Neuropsychological outcomes of pediatric demyelinating diseases: a review. Child Neuropsychol 2018; 24: 575-597.
15. Burton KLO, Williams TA, Catchpoole SE, Brunsdon RK. Long-term neuropsychological outcomes of childhood onset acute disseminated encephalomyelitis (ADEM): a meta-analysis. Neuropsychol Rev 2017; 27: 124-133.
16. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001; 56: 1308-1312.
17. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-988.
18. Gökler B, Ünal F, Pehlivantürk B, Kültür E, Akdemir D, Taner Y. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-Turkish version (K-SADS-PL-T). Turk J Child Adolesc Ment Health 2004; 11: 109-116.
19. Savaşır I, Şahin N. Wechsler Çocuklar İçin Zeka Ölçeği Uygulama Kitapçığı. Ankara: Türk Psikologlar Derneği, 1995.
20. Lapierre D, Braun CMJ, Le Pailleur L. A 54-point verbal-performance IQ discrepancy on the WISe-R: cognitive functioning of a child from an alternative school. Behav Neurol 1992; 5: 97-106.
21. Öy B. Çocuklar için depresyon ölçeği: geçerlik ve güvenirlik çalışması. Türk Psikiyatri Dergisi 1991; 2: 132-136.
22. Achenbach TM, Edelbrock C. Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington: Queen City Printers, 1983.
23. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 800-812.
24. Çakın Memik N, Ağaoğlu B, Coskun A, Üneri ÖS, Karakaya I. The validity and reliability of the Turkish Pediatric Quality of Life Inventory for children 13-18 years old. Turk J Psychiatry 2007; 18: 353-363.
25. Uneri OS, Agaoglu B, Coskun A, Memik NC. Validity and reliability of Pediatric Quality of Life Inventory for 2- to 4-year-old and 5- to 7-year-old Turkish children. Qual Life Res 2008; 17: 307-315.
26. Conners CK, Sitarenios G, Ayearst L. Conners’ Continuous Performance Test Third Edition. In: Kreutzer J, DeLuca J, Caplan B. (eds) Encyclopedia of Clinical Neuropsychology. Cham, Switzerland: Springer, 2018: 1-4.
27. Shilo S, Michaeli O, Shahar E, Ravid S. Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis. Eur J Paediatr Neurol 2016; 20: 361-367.
28. Rostásy K, Nagl A, Lütjen S, et al. Clinical outcome of children presenting with a severe manifestation of acute disseminated encephalomyelitis. Neuropediatrics 2009; 40: 211-217.
29. Deery B, Anderson V, Jacobs R, Neale J, Kornberg A. Childhood MS and ADEM: investigation and comparison of neurocognitive features in children. Dev Neuropsychol 2010; 35: 506-521.
30. Beatty C, Bowler RA, Farooq O, et al. Long-term neurocognitive, psychosocial, and magnetic resonance imaging outcomes in pediatric-onset acute disseminated encephalomyelitis. Pediatr Neurol 2016; 57: 64-73.
31. Iype M, Ts A, Kunju PM, Saradakutty G, Sreedharan M, Ahamed SM. Factors related to long term motor, behavioral, and scholastic outcome in children with acute disseminated encephalomyelitis. Pediatr Neurol 2018; 89: 49-57.
32. Suppiej A, Cainelli E, Casara G, Cappellari A, Nosadini M, Sartori S. Long-term neurocognitive outcome and quality of life in pediatric acute disseminated encephalomyelitis. Pediatr Neurol 2014; 50: 363-367.
33. Sadek AA, Mohamed MA, Abou-Taleb A, Mohammed MI. Pattern and Outcome of Acute Disseminated Encephalomyelitis (ADEM) in children: experience in a tertiary center, Upper Egypt. Electron Physician 2016; 8: 2679-2685.
34. Tideman E, Gustafsson JE. Age-related differentiation of cognitive abilities in ages 3-7. Pers Individ Dif 2004; 36: 1965-1974.
35. Nakao T, Radua J, Rubia K, Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxelbased meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry 2011; 168: 1154-1163.
36. Verma S, Kushwaha S. Intelligence and attention deficit hyperactivity disorder. J Psychol Res 2016; 11: 417-425.
37. Riva D, Taddei M, Bulgheroni S. The neuropsychology of basal ganglia. Eur J Paediatr Neurol 2018; 22: 321- 326.
38. Lewis JD, Fonov VS, Collins DL, Evans AC, Tohka J; for the Brain Development Cooperative Group and the Pediatric Imaging, Neurocognition, and Genetics Study. Cortical and subcortical T1 white/ gray contrast, chronological age, and cognitive performance. Neuroimage 2019; 196: 276-288.
39. Peterson RK, McDonald KP, Vincent M, Williams TS, Dlamini N, Westmacott R. Characterizing language outcomes following childhood basal ganglia stroke. Appl Neuropsychol Child 2019: 1-12.